Holen Sie sich die Stockscreener-App
24.83
2.24%
-0.57
Vorhandelsmarkt:
24.63
-0.20
-0.81%
Schlusskurs vom Vortag:
$25.40
Offen:
$25.36
24-Stunden-Volumen:
2.27M
Relative Volume:
1.52
Marktkapitalisierung:
$2.13B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
39.41
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
+1.68%
1M Leistung:
+26.49%
6M Leistung:
+13.53%
1J Leistung:
+77.61%
1-Tages-Spanne:
$24.43
$25.60
1-Wochen-Bereich:
$23.75
$27.25
52-Wochen-Spanne:
$13.86
$27.25
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
24.83 | 2.19B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
311.54 | 279.99B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
76.04 | 97.18B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
269.60 | 72.66B | 268.22B | 6.55B | 7.44B | 22.67 |
|
ELV
Elevance Health Inc
|
313.99 | 70.31B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
223.29 | 27.53B | 123.11B | 1.58B | 2.44B | 13.03 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Can Progyny Inc. stock sustain revenue growthWeekly Stock Analysis & Smart Investment Allocation Insights - newser.com
New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action - The Manila Times
Progyny (Nasdaq: PGNY) Study: 46% of Men With Fertility Issues Seek Support - Stock Titan
Insider Spends US$1.9m Buying More Shares In Progyny - Yahoo Finance
Insider Sell: Mark Livingston Sells Shares of Progyny Inc (PGNY) - GuruFocus
Progyny Insider Sold Shares Worth $543,227, According to a Recent SEC Filing - MarketScreener
CFO Livingston Sells 21,303 ($543.2K) Of Progyny Inc [PGNY] - TradingView
Visual analytics tools that track Progyny Inc. performancePortfolio Update Summary & AI Enhanced Trading Signals - newser.com
Norman Payson At Progyny Executes Options Exercise, Realizing $876K - Benzinga
Progyny: Growth Has Returned (Rating Upgrade) (NASDAQ:PGNY) - Seeking Alpha
How Progyny Inc. stock reacts to global recession fearsEarnings Miss & Advanced Swing Trade Entry Alerts - newser.com
How hedge fund analytics apply to Progyny Inc. stockQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Is Progyny Inc. stock resilient to inflationJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Can Progyny Inc. stock resist market sell offs2025 Earnings Impact & Reliable Breakout Stock Forecasts - newser.com
How high can Progyny Inc. stock goJuly 2025 Outlook & Comprehensive Market Scan Reports - newser.com
What MACD and RSI say about Progyny Inc.2025 AllTime Highs & Intraday High Probability Alerts - newser.com
Progyny at Jefferies London Conference: Fertility Benefits Expansion By Investing.com - Investing.com India
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
A Look Back at Health Insurance Providers Stocks’ Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack - Yahoo Finance
Progyny (PGNY): Gauging Valuation After Recent Share Price Momentum - Yahoo Finance
Canaccord Genuity Maintains Progyny (PGNY) Hold Recommendation - Nasdaq
Progyny’s SWOT analysis: fertility benefits stock poised for growth amid regulatory changes - Investing.com Nigeria
Progyny (PGNY) CEO Increases Stake, Shares Surge 11% - GuruFocus
Progyny Shares Rise After CEO Anevski Buys $1.9 Million Worth of Shares - MarketScreener
Progyny CEO buys $1.93M in company stock - MSN
Progyny (PGNY) Sees Stock Surge After CEO's Significant Share Pu - GuruFocus
Progyny Insider Bought Shares Worth $1,930,896, According to a Recent SEC Filing - MarketScreener
Progyny stock hits 52-week high at 26.78 USD By Investing.com - Investing.com Australia
Progyny Shares Surge Amid Strong Financial Performance - TipRanks
Eye On Growth: Peter Anevski Adds $1.93M Of Progyny Stock To Portfolio - Benzinga
Progyny, Inc. Stock (PGNY) Opinions on Strong Q3 Earnings and Buyback Announcement - Quiver Quantitative
Anevski Peter, Progyny CEO, buys $1.93 million in PGNY stock By Investing.com - Investing.com Nigeria
Progyny price target raised to $26 from $23 at Canaccord - TipRanks
A Look Back at Health Insurance Providers Stocks' Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack - Finviz
What analyst consensus says on Progyny Inc. stockPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Progyny, Inc. (NASDAQ:PGNY) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable - 富途牛牛
Applying chart zones and confluence areas to Progyny Inc.Market Risk Analysis & Low Risk Investment Opportunities - newser.com
What technical charts say about Progyny Inc. stock2025 Technical Overview & Safe Capital Growth Tips - newser.com
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):